Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3256162

CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    10.2.2016
  • EP published:
    6.12.2023
  • EP application number:
    16711533.6
  • Max expiry date:
    9.2.2036
  • Title in English:
    CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB
  • Language of the patent:
    English

Timeline

Today
10.2.2016EP application
6.12.2023EP Publication

Owner

  • Name:
    Deutsches Krebsforschungszentrum
  • Address:
    Im Neuenheimer Feld 280, 69120 Heidelberg, DE
  • Name:
    Ruprecht-Karls-Universität
  • Address:
    Grabengasse 1, 69117 Heidelberg, DE

Inventor

  • Name:
    GELETNEKY, Karsten
  • Address:
    69121 Heidelberg, DE
  • Name:
    ROMMELAERE, Jean
  • Address:
    69118 Heidelberg, DE
  • Name:
    WICK, Wolfgang
  • Address:
    69117 Heidelberg, DE
  • Name:
    WICK, Antje
  • Address:
    69117 Heidelberg, DE
  • Name:
    DAHM, Michael
  • Address:
    81677 München, DE

Priority

  • Number:
    15154629
  • Date:
    11.2.2015
  • Country:
    EP

Classification

  • Categories:
    C07K 16/22, A61K 39/395, A61K 35/768, A61P 35/00

Upload documents